Arash Pakseresht

Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial

Melanie J. Davies, Louise Færch, Ole Kleist Jeppesen et al. · The Lancet · 2021 · 1.2K citations

Obesity, Diabetes Management, Medicine +6

Perceptions of barriers to effective obesity management in Canada: Results from the ACTION study

Arya M. Sharma, André Bélanger, Veronica Carson et al. · Clinical Obesity · 2019 · 83 citations · Full text

Real‐World Clinical Effectiveness of Liraglutide 3.0 mg for Weight Management in Canada

Sean Wharton, Aiden Liu, Arash Pakseresht et al. · Obesity · 2019 · 75 citations · Full text

Weight loss and persistence with liraglutide 3.0 mg by obesity class in the real‐world effectiveness study in Canada

Sean Wharton, Christiane L. Haase, Elham Kamran et al. · Obesity Science & Practice · 2020 · 26 citations · Full text

Real-world clinical effectiveness of liraglutide 3.0 mg for weight management in Canada

Samantha Hocking, Sean Wharton, Aiden Liu et al. · Obesity Research & Clinical Practice · 2019 · 11 citations

Obesity, Non-pharmacological Intervention, Obesity Management +5